These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis. Leino M, Carlson C, Jaanio E, Koivunen T, Lavikkala H, Riihelä K, Takalo E. Ann Allergy; 1990 Apr; 64(4):398-402. PubMed ID: 2157354 [Abstract] [Full Text] [Related]
6. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis. Ciprandi G, Cerqueti PM, Sacca S, Cilli P, Canonica GW. Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402 [Abstract] [Full Text] [Related]
12. Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Melamed J, Schwartz RH, Hirsch SR, Cohen SH. Ann Allergy; 1994 Jul; 73(1):57-66. PubMed ID: 8030804 [Abstract] [Full Text] [Related]
13. Topical acetylsalicylic acid in the treatment of allergic pollinosic conjunctivitis. Ciprandi G, Buscaglia S, Tosca M, Canonica GW. J Investig Allergol Clin Immunol; 1992 Jul; 2(1):15-8. PubMed ID: 1342877 [Abstract] [Full Text] [Related]
14. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study. Mirone C, Albert F, Tosi A, Mocchetti F, Mosca S, Giorgino M, Pecora S, Parmiani S, Ortolani C. Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374 [Abstract] [Full Text] [Related]
15. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Horak F, Berger UE, Menapace R, Toth J, Stübner PU, Marks B. Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880 [Abstract] [Full Text] [Related]
16. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097 [Abstract] [Full Text] [Related]
17. A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis. Frankland AW, Walker SR. Clin Allergy; 1981 Sep; 11(5):473-8. PubMed ID: 6797754 [Abstract] [Full Text] [Related]
18. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group. J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [Abstract] [Full Text] [Related]
19. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients. Troise C, Bignardi D, Modena P, Pissacroia C, Di Berardino F. Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859 [Abstract] [Full Text] [Related]
20. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G, Hurley C, Turcanu V, Lack G. J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]